Deerfield Management Company, L.P. 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Deerfield Management Company, L.P. disclosed 82 US equity positions worth $8.5bn in its Q1 2026 13F filing. The largest position was NUVALENT INC at 20.8% of the reported book, followed by BROOKDALE SR LIVING INC and COGT.
What did Deerfield Management Company, L.P. own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | 20.8% | $1.8bn | 17,248,450 | – | ||
| 2 | BROOKDALE SR LIVING INC | 6.0% | $505.4m | 306,885,000 | – | ||
| 3 | COGT COGENT BIOSCIENCES INC | Healthcare | 4.1% | $348.1m | 9,043,903 | – | |
| 4 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.7% | $310.4m | 963,351 | – | |
| 5 | VTRS VIATRIS INC | Healthcare | 3.2% | $273.0m | 20,206,170 | – | |
| 6 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.2% | $271.0m | 457,000 | – | |
| 7 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.6% | $223.4m | 2,297,000 | – | |
| 8 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 2.5% | $209.4m | 70,000,000 | – | |
| 9 | ARROWHEAD PHARMACEUTICALS IN | 2.4% | $207.2m | 200,000,000 | – | ||
| 10 | CELC CELCUITY INC | Healthcare | 2.3% | $195.6m | 1,714,000 | – | |
| 11 | CNC CENTENE CORP DEL | Healthcare | 2.3% | $193.7m | 5,917,091 | – | |
| 12 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 1.9% | $160.2m | 35,606,974 | – | |
| 13 | BKD BROOKDALE SR LIVING INC | Healthcare | 1.9% | $159.2m | 11,637,032 | – | |
| 14 | VERA VERA THERAPEUTICS INC | Healthcare | 1.8% | $149.7m | 3,722,100 | – | |
| 15 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.8% | $148.7m | 1,979,669 | – | |
| 16 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.7% | $143.2m | 15,038,000 | – | |
| 17 | INSP INSPIRE MED SYS INC | Healthcare | 1.6% | $139.4m | 2,703,238 | – | |
| 18 | LEGN LEGEND BIOTECH CORP | Healthcare | 1.6% | $139.1m | 7,687,638 | – | |
| 19 | AHCO ADAPTHEALTH CORP | Healthcare | 1.6% | $136.6m | 11,477,730 | – | |
| 20 | NEWAMSTERDAM PHARMA COMPANY | 1.6% | $136.5m | 4,264,789 | – | ||
| 21 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 1.2% | $105.7m | 4,520,000 | – | |
| 22 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.2% | $98.6m | 1,573,297 | – | |
| 23 | CATALYST PHARMACEUTICALS INC | 1.2% | $97.6m | 3,943,600 | – | ||
| 24 | INDV INDIVIOR PHARMACEUTICALS INC | Healthcare | 1.1% | $94.4m | 3,097,790 | – | |
| 25 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.1% | $94.0m | 1,615,696 | – | |
| 26 | IONIS PHARMACEUTICALS INC | 1.1% | $90.6m | 60,000,000 | – | ||
| 27 | PHVS PHARVARIS N V | Healthcare | 1.0% | $88.3m | 3,126,042 | – | |
| 28 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.0% | $88.3m | 3,779,900 | – | |
| 29 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.0% | $86.8m | 4,146,813 | – | |
| 30 | ALIGNMENT HEALTHCARE INC | 1.0% | $85.9m | 61,000,000 | – | ||
| 31 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.0% | $85.6m | 1,019,813 | – | |
| 32 | PFE PFIZER INC | Healthcare | 1.0% | $85.4m | 3,040,000 | – | |
| 33 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 0.9% | $80.4m | 610,000 | – | |
| 34 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.9% | $79.8m | 3,723,131 | – | ||
| 35 | SVRA SAVARA INC | Healthcare | 0.9% | $74.1m | 13,569,000 | – | |
| 36 | ZENAS BIOPHARMA INC | 0.8% | $67.3m | 65,000,000 | – | ||
| 37 | ENHABIT INC | 0.8% | $66.9m | 4,747,746 | – | ||
| 38 | NEOGENOMICS INC | 0.8% | $66.7m | 72,689,000 | – | ||
| 39 | GMAB GENMAB A/S | Healthcare | 0.8% | $66.1m | 2,462,000 | – | |
| 40 | BIO BIO RAD LABS INC | Healthcare | 0.7% | $63.0m | 226,070 | – | |
| 41 | LNTH LANTHEUS HLDGS INC | Healthcare | 0.7% | $62.8m | 827,999 | – | |
| 42 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 0.7% | $60.3m | 7,503,812 | – | |
| 43 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.7% | $59.4m | 1,823,500 | – | |
| 44 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 0.7% | $56.1m | 2,210,100 | – | |
| 45 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 0.6% | $51.0m | 1,530,008 | – | |
| 46 | BLTE BELITE BIO INC | Healthcare | 0.6% | $48.5m | 304,013 | – | |
| 47 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.6% | $48.1m | 851,556 | – | |
| 48 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 0.6% | $46.7m | 561,170 | – | |
| 49 | CERT CERTARA INC | Healthcare | 0.5% | $44.5m | 7,808,605 | – | |
| 50 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 0.5% | $43.7m | 4,885,446 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.